Health-care companies fell after reports that UnitedHealth Group was under federal investigation. Shares of UnitedHealth plunged after reports the Department of Justice was investigating allegations ...

Merck will have early-stage opportunities to help startups set up for future success in the pharmaceutical and life sciences fields.

As has been the case for several quarters now, Merck KGaA’s life science business continues to serve as a weathervane for the ...

Gain insight on WELL Health Technologies and Merck in the latest Market Talks covering the Health Care sector.

Cash and cash equivalents as of March 31, 2025 were $102.3 million. Due in part to the strategic restructuring and reprioritization plan that was announced on May 6, 2025, Mersana expects that its ...

Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet ...

Shares fell after the company cut its full-year guidance on the back of challenging macroeconomic conditions and ...

Germany's Merck KGaA shares plunged after the company slashed its full-year outlook on the back of uncertainty around tariffs and foreign-exchange headwinds. In European morning trading shares were ...

Germany's Merck KGaA slashed its full-year outlook on the back of challenging macroeconomic conditions and foreign-exchange headwinds.

Merck KGaA reduced its outlook for sales and profit growth this year, citing the impact of a weak US dollar and uncertainty ...

The global CRISPR Market, valued at US$2.90 billion in 2024, is forecasted to grow at a robust CAGR of 11.2%, reaching ...

German healthcare and materials group Merck KGaA has dropped a surcharge on life sciences sector orders within China ...